Rapid emergence of echinocandin resistance during Candida kefyr fungemia treatment with caspofungin

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 5, 2013, Pages 2380-2382

  Fekkar, A ^a,b   Meyer, I ^a   Brossas, J Y ^b   Dannaoui, E ^c   Palous, M ^a   Uzunov, M ^a   Nguyen, S ^a   Leblond, V ^a   Mazier, D ^a,b,d   Datry, A ^a,b,d  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASPOFUNGIN; ECHINOCANDIN; FLUCONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BLOOD CULTURE; CANDIDEMIA; CASE REPORT; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; KLUYVEROMYCES MARXIANUS; MINIMUM INHIBITORY CONCENTRATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANTIFUNGAL AGENTS; CANDIDA; CANDIDEMIA; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; ECHINOCANDINS; FATAL OUTCOME; FEMALE; FUNGAL PROTEINS; GLUCOSYLTRANSFERASES; HUMANS; KLUYVEROMYCES; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION;

EID: 84876257690     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02037-12     Document Type: Article

References (14)

1. Pfaller MA, Diekema DJ. 2012. Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012. J. Clin. Microbiol. 50:2846-2856.
2. Ohyama T, Miyakoshi S, Isono F. 2004. FKS1 mutations responsible for selective resistance of Saccharomyces cerevisiae to the novel 1,3-betaglucan synthase inhibitor arborcandin C. Antimicrob. Agents Chemother. 48:319-322.
3. Laverdiere M, Lalonde RG, Baril JG, Sheppard DC, Park S, Perlin DS. 2006. Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis. J. Antimicrob. Chemother. 57:705-708.
4. Garcia-Effron G, Kontoyiannis DP, Lewis RE, Perlin DS. 2008. Caspofungin- resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies. Antimicrob. Agents Chemother. 52:4181-4183.
5. Baixench MT, Aoun N, Desnos-Ollivier M, Garcia-Hermoso D, Bretagne S, Ramires S, Piketty C, Dannaoui E. 2007. Acquired resistance to echinocandins in Candida albicans: case report and review. J. Antimicrob. Chemother. 59:1076-1083.
6. Dannaoui E, Desnos-Ollivier M, Garcia-Hermoso D, Grenouillet F, Cassaing S, Baixench MT, Bretagne S, Dromer F, Lortholary O, French Mycoses Study Group. 2012. Candida spp. with acquired echinocandin resistance, France, 2004-2010. Emerg. Infect. Dis. 18:86-90.
7. Garcia-Effron G, Lee S, Park S, Cleary JD, Perlin DS. 2009. Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-β-D-glucan synthase: implication for the existing susceptibility breakpoint. Antimicrob. Agents Chemother. 53:3690-3699.
8. Pfaller MA, Diekema DJ, Andes D, Arendrup MC, Brown SD, Lockhart SR, Motyl M, Perlin DS, CLSI Subcommittee for Antifungal Testing. 2011. Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. Drug Resist. Updat. 14:164-176.
9. Katiyar S, Pfaller M, Edlind T. 2006. Candida albicans and Candida glabrata clinical isolates exhibiting reduced echinocandin susceptibility. Antimicrob. Agents Chemother. 50:2892-2894.
10. Katiyar SK, Edlind TD. 2009. Role for Fks1 in the intrinsic echinocandin resistance of Fusarium solani as evidenced by hybrid expression in Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 53:1772-1778.
11. Sun HY, Singh N. 2010. Characterisation of breakthrough invasive mycoses in echinocandin recipients: an evidence-based review. Int. J. Antimicrob. Agents 35:211-218.
12. Pfaller MA, Boyken L, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, Diekema DJ. 2008. In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance. J. Clin. Microbiol. 46:150-156.
13. Parmeland L, Gazon M, Guerin C, Argaud L, Lehot JJ, Bastien O, Allaouchiche B, Michallet M, Picot S, Bienvenu AL, Study Group at Hospices Civils de Lyon. 2013. Candida albicans and non-Candida albicans fungemia in an institutional hospital during a decade. Med. Mycol. 51:33-37.
14. Krcmery V, Barnes AJ. 2002. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J. Hosp. Infect. 50:243-260.